Organism 57840 - Physalis alkekengi (SOLANACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon3218
FamilySOLANACEAE
GenusPHYSALIS
SpeciesALKEKENGI
Species authority
SubspeciesVAR.FRANCHETI
Subspecies authority
Comment
CitationASANO,N: KATO,A: OSEKI,K: KIZU,H: MATSUI,K:. (1995). CALYSTEGINS OF PHYSALIS ALKEKENGI VAR.FRANCHETI (SOLANACEAE) STRUCTURE DETERMINATION AND THEIR GLYCOSIDASE INHIBITORY ACTIVITIES.. 229(2)
Geographical areaEASTERN ASIA
CountryJAPAN

Experiments

Filters
Worktypes (8)
18
18
6
6
6
4
4
2
No match
Pharmacology (5)
6
6
5
1
6
No match
Compounds (6)
4
4
4
4
4
4
No match
24 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
171505
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-2
171506
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-2
171507
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALPHA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-2
171508
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-2
171509
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-3
171510
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-5
171511
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-3
171512
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALPHA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-3
171513
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-3
171514
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-5
171515
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALPHA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-5
171516
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE A-5
171517
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-3
171518
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-1
171519
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-3
171520
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALPHA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-3
171521
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-3
171522
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-1
171523
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALPHA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-1
171524
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE B-1
171525
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE C-1
171526
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GLUCOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE C-1
171527
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ATP-ASE(CA++/MG++) STIMULATION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE C-1
171528
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
BETA-GALACTOSIDASE INHIBITION
Physalis alkekengi (SOLANACEAE)
CALYSTEGINE C-1
Show SPARQL Queries (1)